Additionally, claudin-7, also identified as a biomarker of CICs, was found to be expressed on PDA CIC derived-EVs and impacted PDA non-CIC motility, invasiveness, metastatic dissemination and lymphangiogenesis. The gene discussed is CLDN7; the disease is Patent ductus arteriosus.